Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-01-03
1985-10-29
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 95, 546 96, A61K 3147, C07D45506
Patent
active
045501149
ABSTRACT:
The invention concerns benzoquinolizines of general formula ##STR1## and their pharmaceutically acceptable acid addition salts. In the formula R.sup.1 and R.sup.2 which may be the same or different each represent hydrogen, lower alkyl, lower alkoxy or halogen, R.sup.3 represents hydrogen or lower alkyl and R.sup.4 represents a heterocyclic radical attached to the SO.sub.2 group through a carbon atom of the heterocyclic ring. The compounds possess .alpha..sub.2 -adrenoceptor antagonistic activity in warm blooded animals.
REFERENCES:
patent: 4076820 (1978-02-01), Archibald et al.
patent: 4183937 (1980-01-01), Ward
John Wyeth & Brother Limited
Schwartz Richard A.
Tarnowski George
LandOfFree
Benzoquinolizines as .alpha..sub.2 -adrenoceptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzoquinolizines as .alpha..sub.2 -adrenoceptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoquinolizines as .alpha..sub.2 -adrenoceptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-728741